Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Carcinoma, Non-Small-Cell Lung 22Glioblastoma 15Gliosarcoma 13Prostatic Neoplasms 12Squamous Cell Carcinoma of Head and Neck 11Breast Neoplasms 11Head and Neck Neoplasms 10Pancreatic Neoplasms 9Lung Neoplasms 9Brain Neoplasms 7Adenocarcinoma of Lung 6Salivary Gland Neoplasms 5Astrocytoma 5Rectal Neoplasms 4Neoplasm Metastasis 4Glioma 4Central Nervous System Neoplasms 4Carcinoma, Intraductal, Noninfiltrating 4Adenocarcinoma, Bronchiolo-Alveolar 4Uterine Cervical Neoplasms 3Urinary Bladder Neoplasms 3Stomach Neoplasms 3Sarcoma 3Ovarian Neoplasms 3Oligodendroglioma 3Liver Neoplasms 3Colorectal Neoplasms 3Carcinoma, Hepatocellular 3Carcinoma, Ductal, Breast 3Wilms Tumor 2

Interventions

tremelimumab 1durvalumab 1Radiotherapy, Intensity-Modulated 1Radiotherapy, Conformal 1Immunoglobulin G 1Disulfides 1Brachytherapy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Metastatic Malignant Female Reproductive System Neoplasm × Radiotherapy, Conformal × Clear all
NCT04516135 2026-02-25

Single Fraction or Multi-fraction Palliative Radiation Therapy for the Improvement of Quality of Life in Patients With Metastatic Gynecologic Cancers

M.D. Anderson Cancer Center

Phase 2 Active not recruiting
28 enrolled

Metastatic Malignant Female Reproductive System Neoplasm

Data powered by HemOnc (CC BY 4.0) Colophon âš¡